Table 2.
WBC | 4.85×103 | /μL | Cr | 0.53 | mg/dL | HBsAg | (-) | |
Hb | 11.5 | g/dL | Na | 143 | mEq/L | HBcAb | (-) | |
Plt | 13.0×104 | /μL | K | 3.7 | mEq/L | HCVAb | (-) | |
TP | 6.9 | g/dL | Glu | 82 | mg/dL | CMVIgM | (-) | |
Alb | 3.5 | g/dL | HbA1c | 5.4 | % | EBV-VCAIgG | 20 | |
T-Bil | 1.1 | mg/dL | CRP | 0.26 | mg/dL | EBV-VCAIgM | (-) | |
AST | 78 | U/L | EBNA | 40 | ||||
ALT | 42 | U/L | IgG | 1,429 | mg/dL | |||
LDH | 222 | U/L | IgA | 239 | mg/dL | PT | 52.6 | % |
γGTP | 69 | U/L | IgM | 89 | mg/dL | FDP | 1.5> | mg/mL |
TCHO | 153 | mg/dL | ANA | ×320 | ||||
TG | 72 | mg/dL | AMA | (-) |
WBC: white blood cell, Hb: hemoglobin, Plt: platelet, TP: total protein, Alb: albumin, T-Bil: total bilirubin, AST: aspartate aminotransferase, ALT: alanine aminotransferase, LDH: lactase dehydrogenase, ALP: alkaline phosphatase, γ-GTP: gamma-glutamyltranspeptidase, TCHO: total cholesterol, TG: triglyceride, Cr: creatinine, Glu: glucose, HbA1c: hemoglobin A1c, CRP: C-reactive protein, ANA: antinuclear antibody, AMA: anti-mitochondrial antibodies, HBsAg: hepatitis B surface antigen, HBcAb: hepatitis B core antibody, HCVAb: anti-hepatitis C antibody, CMVIgM: cytomegalovirus IgM, EBV-VCA: Epstein-Barr virus-viral capsid antigen, EBNA: EBV nuclear antigen, PT: prothrombin time, FDP: fibrin degradation products